Weibull H, Bergqvist D, Jonsson K, Hulthén L, Mannhem P, Bergentz S E
The Department of Surgery, Lund University, Malmö General Hospital, Sweden.
Eur J Vasc Surg. 1991 Jun;5(3):291-301. doi: 10.1016/s0950-821x(05)80513-4.
The aim of this study was to investigate the long-term results of percutaneous transluminal angioplasty of atherosclerotic renal artery stenosis (PTRA) in patients with renovascular hypertension with or without impending renal insufficiency who were followed up intensively with aggressive reintervention. Diagnostic work-up was based on angiography, pressure gradient and renal venous renin measurement. Patients were scheduled for regular follow-up after the PTRA and a deterioration in blood pressure or renal function was an indication for re-evaluation, and reintervention if necessary. Sixty-five patients had 71 renal artery stenoses where PTRA was attempted. It was technically successful in 59 stenoses and two occlusions and failed in ten (14%). At the end of follow-up (median 56 months [2-99]), the primary patency rate was 55%, 27 had restenosed and four were occluded, all but two within 12 months. Seventeen were treated by a further PTRA and eight by surgical reconstruction. At the end of follow-up the secondary patency after all interventions was 90%. One patient died 1 month after PTRA, and at the end of follow-up 21 patients (32%) had died, most of them (80%) from cardiovascular disease. Multivariate analyses showed a significantly reduced survival rate in patients with multiocular atherosclerosis, renal insufficiency, contralateral renal artery stenosis and ischaemic heart disease. At the end of follow-up 90% of the patients were cured or improved with regard to blood pressure. In patients with impending renal insufficiency renal function was improved in 50% and unchanged in 39%. With this strategy 55% of the patients needed only one treatment with PTRA, 25% needed a re-PTRA and 20% had to be operated on. PTRA can be recommended as initial treatment of atherosclerotic renal artery stenosis provided intensive follow-up and aggressive reintervention are performed when indicated.
本研究的目的是调查经皮腔内血管成形术治疗动脉粥样硬化性肾动脉狭窄(PTRA)对有或无即将发生肾功能不全的肾血管性高血压患者的长期疗效,这些患者接受了积极的再次干预并进行了密切随访。诊断检查基于血管造影、压力梯度和肾静脉肾素测量。患者在PTRA后安排定期随访,血压或肾功能恶化是重新评估的指征,必要时进行再次干预。65例患者有71处肾动脉狭窄,尝试进行PTRA。其中59处狭窄和2处闭塞在技术上成功,10处(14%)失败。随访结束时(中位时间56个月[2 - 99个月]),原发性通畅率为55%,27处再狭窄,4处闭塞,除2处外均在12个月内发生。17例接受了进一步的PTRA治疗,8例接受了手术重建。随访结束时,所有干预后的继发性通畅率为90%。1例患者在PTRA后1个月死亡,随访结束时21例患者(32%)死亡,其中大多数(80%)死于心血管疾病。多因素分析显示,患有多眼动脉粥样硬化、肾功能不全、对侧肾动脉狭窄和缺血性心脏病的患者生存率显著降低。随访结束时,90%的患者血压得到治愈或改善。在即将发生肾功能不全的患者中,50%的患者肾功能得到改善,39%的患者肾功能无变化。采用这种策略,55%的患者仅需接受一次PTRA治疗,25%的患者需要再次PTRA治疗,20%的患者必须接受手术治疗。如果在有指征时进行密切随访和积极的再次干预,PTRA可被推荐为动脉粥样硬化性肾动脉狭窄的初始治疗方法。